These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2162036

  • 1. Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.
    Griffiths NM, Simmons NL.
    Pflugers Arch; 1990 Apr; 416(1-2):80-7. PubMed ID: 2162036
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 6. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL, Feinstein DL, Yu N, Sorg O, Rossier C, Magistretti PJ.
    Brain Res; 1992 Jul 31; 587(1):1-12. PubMed ID: 1326373
    [Abstract] [Full Text] [Related]

  • 7. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 31; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 8. 125I-vasoactive intestinal peptide binding in human kidney.
    Charlton BG, Neal DE, Simmons NL.
    Miner Electrolyte Metab; 1991 Jun 31; 17(6):372-6. PubMed ID: 1823387
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F, Jürgens H, Winkelmann W, Keck E.
    Cell Signal; 1989 Jun 31; 1(5):435-46. PubMed ID: 2561912
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M, Carlquist M, Maletti M, Marie JC.
    FEBS Lett; 1993 Feb 22; 318(1):35-40. PubMed ID: 8382169
    [Abstract] [Full Text] [Related]

  • 11. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK, Barnett W, Coy DH, Tougas G, Daniel EE.
    J Pharmacol Exp Ther; 1991 Sep 22; 258(3):986-91. PubMed ID: 1653848
    [Abstract] [Full Text] [Related]

  • 12. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    J Mol Neurosci; 2003 Apr 22; 20(2):153-62. PubMed ID: 12794309
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
    Nguyen TT, Krco CJ, Gores A, Go VL.
    Immunol Invest; 1987 Nov 22; 16(7):555-77. PubMed ID: 2832322
    [Abstract] [Full Text] [Related]

  • 14. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
    Dickinson KE, Schachter M, Miles CM, Coy DH, Sever PS.
    Peptides; 1986 Nov 22; 7(5):791-800. PubMed ID: 3025822
    [Abstract] [Full Text] [Related]

  • 15. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S, Said SI.
    J Biol Chem; 1987 Jan 05; 262(1):158-62. PubMed ID: 3025200
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 05; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

  • 17. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
    Robberecht P, Waelbroeck M, De Neef P, Camus JC, Gourlet P, Christophe J.
    Life Sci; 1988 Feb 05; 42(5):505-10. PubMed ID: 2828794
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
    Gespach C, Bawab W, Chastre E, Emami S, Yanaihara N, Rosselin G.
    Biochem Biophys Res Commun; 1988 Mar 15; 151(2):939-47. PubMed ID: 2831906
    [Abstract] [Full Text] [Related]

  • 19. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Mar 15; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 20. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors.
    Calvo JR, Goberna R, Guerrero JM.
    Biosci Rep; 1986 Aug 15; 6(8):727-33. PubMed ID: 3028522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.